Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Phathom Pharmaceuticals, Inc.

PHAT

Valuace

Růst

Zdraví

Cena

$ 11.42

-0.92 (-6.14%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018
Total Revenues	175.1	175.1	55.3	0.7	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	22.6	22.6	8.0	0.2	0.0	0.0	0.0	0.0	0.0
Gross Profit	152.5	152.5	47.3	0.5	0.0	0.0	0.0	0.0	0.0

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	57.6	49.5	39.5	28.5	29.7	16.4	7.3	1.9	0.7	0.0
Cost of Revenues	7.6	6.2	5.0	3.7	3.8	2.4	1.4	0.4	-0.2	0.1
Gross Profit	49.9	43.3	34.5	24.8	25.8	14.0	5.9	1.5	0.9	-0.1

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018
R&D Expenses	0.0	0.0	0.0	49.9	71.4	72.3	98.1	99.3	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	117.9	101.0	62.7	27.5	6.9	1.2
Depreciation & Amortization	0.6	0.6	0.8	0.6	2.0	-2.0	1.1	-48.5	-0.1
Total Operating Expenses	312.5	312.5	324.7	167.8	172.4	135.1	125.7	106.2	1.2
Operating Income	-160.0	-160.0	-277.5	-167.3	-172.4	-135.1	-125.7	-106.2	-1.2

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	12.3
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	23.4
Depreciation & Amortization	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1
Total Operating Expenses	55.9	58.6	94.4	103.7	85.3	84.8	83.2	71.4	70.4	35.7
Operating Income	-5.9	-15.3	-59.9	-78.9	-59.4	-70.8	-77.3	-70.0	-69.9	-35.7

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018
Interest Income	7.0	7.0	15.2	7.9	2.1	0.0	1.1	1.1	0.0
Interest Expense	171.5	68.1	72.0	42.0	27.3	6.8	4.6	4.2	0.0
Other Expense	-61.3	-61.3	-56.9	-34.3	-25.3	-8.8	-3.4	-148.9	-0.1
IBT	-221.2	-221.2	-334.3	-201.6	-197.7	-143.9	-129.1	-255.1	-1.3
Income Tax Expense	0.0	0.0	0.0	0.0	25.3	4.2	4.3	-45.4	0.0
Net Income	-221.2	-221.2	-334.3	-201.6	-223.0	-148.1	-133.3	-209.7	-1.3

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	1.2	1.4	1.8	2.6	3.5	3.7	3.6	4.3	3.3	2.7
Interest Expense	119.8	16.1	17.5	18.1	18.6	18.5	17.8	17.2	13.0	10.1
Other Expense	-15.2	-14.7	-15.9	-15.5	-15.0	-14.8	-14.1	-12.9	-9.7	-7.6
IBT	-21.1	-30.0	-75.8	-94.3	-74.5	-85.6	-91.4	-82.9	-79.6	-43.2
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-16.7	7.3
Net Income	-21.1	-30.0	-75.8	-94.3	-74.5	-85.6	-91.4	-82.9	-79.6	-43.2

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018
EPS	$0.00	$0.00	$0.00	$-3.93	$-5.70	$-4.00	$-4.01	$-18.45	$-0.15
EPS Diluted	$0.00	$0.00	$0.00	$-3.93	$-5.70	$-4.00	$-4.01	$-18.45	$-0.15
Shares Outstanding	72.9	72.9	63.2	51.3	39.1	37.0	33.2	11.4	8.6
Diluted Shares Outstanding	72.9	72.9	63.2	51.3	39.1	37.0	33.2	11.4	8.6

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-1.39	$-0.76
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-1.39	$-0.76
Shares Outstanding	72.9	73.4	72.5	72.0	71.0	64.6	58.6	58.4	57.3	56.8
Diluted Shares Outstanding	72.9	73.4	72.5	72.0	71.0	64.6	58.6	58.4	57.3	56.8

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018
Cash And Equivalents	276.2	297.3	381.4	155.4	183.3	287.5	243.8	0.9
Short Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	276.2	297.3	381.4	155.4	183.3	287.5	243.8	0.9
Accounts Receivable	10.9	38.8	1.6	0.0	0.0	0.1	0.0	0.0
Inventory	2.2	3.2	1.2	0.0	0.0	-0.1	0.0	0.0
Other Current Assets	15.5	20.9	13.2	5.1	3.3	3.9	11.8	0.0
Total Current Assets	304.8	360.1	397.4	160.5	186.5	291.4	255.6	0.9

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	135.2	149.6	212.3	297.3	334.7	276.2	322.2	381.4	213.7	248.8
Short Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	135.2	149.6	212.3	297.3	334.7	276.2	322.2	381.4	213.7	248.8
Accounts Receivable	55.8	51.3	36.4	38.8	21.1	10.9	3.9	1.6	0.0	0.0
Inventory	3.6	3.4	3.2	3.2	3.1	2.2	1.5	1.2	0.1	0.1
Other Current Assets	13.2	14.6	13.1	20.9	15.0	15.5	12.7	13.2	12.9	8.8
Total Current Assets	207.8	218.9	264.9	360.1	373.8	304.8	340.3	397.4	226.7	257.7

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018
Net Property, Plant & Equipment	2.9	2.1	3.6	3.5	2.6	3.4	1.4	0.0
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	2.9	2.9	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	8.9	13.2	12.8	0.8	0.3	0.4	0.2	0.0
Total Long-Term Assets	14.6	18.2	16.4	4.3	2.9	3.7	1.6	0.0
Total Assets	319.4	378.3	413.8	164.8	189.4	295.1	257.2	0.9

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	3.9	2.1	1.7	2.1	2.5	2.9	3.2	3.6	3.7	3.0
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	2.9	2.9	2.9	2.9	2.9	2.9	2.9	2.9	2.9	0.5
Other Long-Term Assets	25.8	26.4	24.7	13.2	7.9	8.9	10.1	9.9	3.8	3.7
Total Long-Term Assets	32.5	31.3	29.3	18.3	13.2	14.6	16.2	16.4	10.3	7.3
Total Assets	240.3	250.2	294.2	378.5	387.0	319.4	356.5	413.8	237.0	265.0

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018
Accounts Payable	7.7	10.5	12.6	10.0	5.2	16.8	0.7	0.1
Short-Term Debt	10.6	20.3	0.7	0.7	0.5	7.8	0.2	2.0
Other Current Liabilities	28.7	54.9	25.5	15.5	13.3	30.9	0.4	2.1
Current Liabilities	47.0	85.7	38.8	26.2	18.9	55.5	3.7	2.2

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	1.1	4.0	11.6	10.5	7.1	7.7	8.4	12.6	5.8	4.2
Short-Term Debt	0.6	22.0	17.6	20.3	20.9	10.6	17.2	0.7	0.7	0.7
Other Current Liabilities	91.5	65.8	44.8	54.9	37.3	28.7	17.8	25.5	17.5	16.7
Current Liabilities	93.1	91.8	74.0	85.7	65.3	47.0	43.5	38.8	24.0	21.5

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018
Long-Term Debt	495.6	534.7	138.3	96.4	90.9	41.2	23.4	0.0
Capital Leases	0.1	0.5	1.2	1.8	1.7	2.0	0.8	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	553.2	631.9	486.6	239.6	117.3	100.8	29.2	2.2

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	2.1	552.7	547.1	534.7	498.1	495.7	451.8	138.3	99.9	98.6
Capital Leases	2.7	0.8	0.3	0.0	0.0	0.1	0.3	1.2	1.3	1.5
Def. Tax Liability	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	662.8	656.1	632.6	632.0	574.2	553.2	505.0	486.6	254.8	247.4

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-1,103.0	-1,263.0	-928.7	-727.1	-529.4	-385.5	-256.4	-1.3
Comprehensive Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Common Equity	-233.8	-253.6	-72.8	-74.8	72.2	194.3	228.0	-1.3

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-1,463.1	-1,433.1	-1,357.3	-1,263.0	-1,188.6	-1,103.0	-1,011.5	-928.7	-849.1	-805.9
Comprehensive Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Common Equity	-422.5	-405.8	-338.4	-253.6	-187.1	-233.8	-148.5	-72.8	-17.8	17.6

Other		TTM	2024	2023	2022	2021	2020	2019	2018
Total Debt		506.4	554.9	139.0	97.1	91.3	49.0	23.6	2.0
Book Value		-233.8	-253.6	-72.8	-74.8	72.2	194.3	228.0	-1.3

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		-422.5	-405.8	-338.4	-253.6	-187.1	-233.8	-148.5	-72.8	-17.8	17.6

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018
Net Income	-297.1	-221.2	-334.3	-201.6	-197.7	-143.9	-129.1	-255.1	-1.3
Depreciation & Amortization	0.7	0.6	0.8	0.6	0.6	0.5	0.3	0.0	0.0
Stock-Based Compensation	42.4	28.7	24.0	45.0	24.1	16.8	5.8	0.4	0.0
Change Working Capital	-9.4	-12.4	-15.3	-13.6	5.4	-27.5	51.7	-9.5	0.2
Change In Accounts Receivable	-10.9	-39.3	-37.2	-1.6	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	18.5	34.1	34.9	6.4	8.7	-9.8	24.0	2.3	0.2
Change In Inventories	-9.5	-11.8	-6.1	-9.4	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	66.1	37.5	58.0	32.1	21.0	5.4	1.6	131.5	0.1
Cash from Operations	-215.5	0.0	0.0	-137.6	-146.5	-148.6	-69.7	-36.5	-1.0

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-21.1	-30.0	-75.8	-94.3	-74.5	-85.6	-91.4	-82.9	-79.6	-43.2
Depreciation & Amortization	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1
Stock-Based Compensation	5.6	9.3	8.3	5.5	6.7	5.6	6.1	5.6	24.6	6.1
Change Working Capital	4.0	-1.6	-6.0	-8.9	-9.0	1.4	-0.6	-7.0	0.7	-2.4
Change In Accounts Receivable	-22.3	-4.5	-14.9	2.4	-17.7	-10.2	-7.0	-2.2	-1.6	0.0
Change In Accounts Payable	27.6	1.1	12.4	-7.0	19.9	11.3	8.7	-5.0	10.3	4.6
Change In Inventories	2.0	0.4	-1.9	-12.3	-5.6	-0.4	0.3	-0.4	-9.3	0.0
Other Non-cash Items	6.4	8.0	10.6	12.6	13.2	14.8	15.1	15.0	10.3	7.5
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-43.8	-31.9

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019
Capital Expenditure	-1.5	-0.2	-0.1	-1.6	-1.0	-0.3	-1.0	-25.3
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities	-1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Investing	-1.5	0.0	0.0	-1.6	-1.0	-0.3	-1.0	-25.3

Cash Flow From Investing Activities	4-2025	2-2025	3-2024	4-2023	3-2023
Capital Expenditure	0.1	-0.1	0.1	-0.5	-0.9
Acquisitions	0.0	0.0	0.0	0.0	0.0
Investments	0.0	0.0	0.0	0.0	0.0
Sales of Investment	0.0	0.0	0.0	0.0	0.0
Other Investing Activities	0.0	0.0	0.0	-1.7	0.0
Cash from Investing	0.0	0.0	0.0	-0.5	-0.9

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018
Debt Repaid	-246.6	0.0	0.0	39.3	0.0	-54.1	0.0	0.0	0.0
Debt Issued	653.7	554.9	415.9	81.3	5.7	96.4	25.4	21.6	2.0
Issuance of Common Stock	-141.4	0.0	0.0	155.5	24.6	1.3	88.8	191.5	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	221.9	0.0	0.0	172.8	95.4	97.5	25.6	113.2	1.9
Cash from Financing	246.7	0.0	0.0	367.6	120.0	44.7	114.5	304.6	1.9

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	2.7	-571.8	9.9	9.7	36.0	12.6	37.3	330.0	38.4	1.3
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-141.4	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.0	0.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.0	0.0

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018
Net Change in Cash		29.7	-167.3	-84.1	228.4	-27.5	-104.2	43.7	242.9	0.9
Closing Cash Balance		276.2	132.8	300.1	384.3	155.9	183.3	287.5	243.8	0.9

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-5.2	-14.4	-62.7	-84.9	-37.4	58.4	-46.0	-59.2	167.7	-32.8
Closing Cash Balance		132.8	138.0	152.4	215.2	300.1	337.5	276.2	322.2	384.3	216.5

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018
Free Cash Flow		-217.0	-166.8	-266.9	-139.2	-147.6	-148.9	-70.7	-61.8	-1.0
Real Free Cash Flow		-259.4	-195.5	-291.0	-184.2	-171.7	-165.8	-76.6	-62.2	-1.0

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-4.9	-14.1	-62.7	-84.9	-63.5	-63.5	-70.8	-69.1	-44.3	-32.9
Real Free Cash Flow		-10.5	-23.4	-71.0	-90.5	-70.1	-69.1	-76.9	-74.7	-68.9	-39.0